Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases

Neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's, represent some of the most challenging and debilitating conditions affecting the aging population, with limited therapeutic options available. Recent advances in nanotechnology and natural product research open new avenues for intervention. The synergistic potential of engineered nanoparticles and bioactive secondary metabolites, such as flavonoids and terpenoids, crosses biological barriers and modulates oxidative stress and inflammation. This emerging interdisciplinary approach offers promising strategies for medical diagnosis, drug delivery, and disease modification in the fight against neurodegeneration. Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases explores two emerging therapeutic strategies in the treatment of neurodegenerative diseases. It examines the synergistic potential of nanoparticles and secondary metabolites. Covering topics such as neurodegenerative disease, metabolites, and nanoparticles, this book is an excellent resource for academicians, medical and healthcare professionals, engineers, and scientists.